Freund's adjuvant (CFA) into the hindpaw. A rapid and marked increase in NPY rnRNA expression was observed in ipsilateral dorsal horn neurons 6 hr after inoculation as compared to the contralateral side. This was mainly found in the medial part of spinal lamina II. The peak level (66% increase) was reached at 3 d. In adjacent sections of the spinal cord, 96% and 33% increases were found in the number of dynorphin and enkephalin mRNA-positive neurons, respectively. Unilateral inflammation also induced a moderate increase in NPY-like immunoreactivity and the number of NPY-immunoreactive neurons in the medial part of the ipsilateral spinal dorsal horn. In addition, a marked elevation in the expression of c-Fos-like protein was observed in ipsilateral spinal neurons in laminae I, II, and V. However, no NPY mRNA-positive or NPY-immunoreactive neurons were found in the ipsilateral and contralateral DRGs in rats receiving CFA injection. Furthermore, a marked upregulation of NPY (Y 1) receptor mRNA expression was detected in the ipsilateral spinal dorsal horn 1 d and 3 d after inoculation.
These Yl receptor mRNApositive cells were mainly distributed in the medial laminae II and Ill. Numerous Y 1 mRNA-positive, small neuron profiles were found bilaterally in the DRGs in CFA-treated rats. CFA evoked a 34% increase in the number of Y 1 mRNA-positive neurons in ipsilateral DRGs as compared to contralateral DRGs. The distinct upregulation of NPY and NPY (Yl) receptor in response to peripheral inflammation suggests an involvement of NPY in the response to inflammation and in nociception.
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Injection of complete Freund's adjuvant (CFA), carrageenan, formalin, or other irritative chemicals into the hindpaw of the rat produces an intense inflammation characterized by erythema, edema, and hyperthermia that is limited to the injected paw Dubner and Ruda, 1992; Solodkin et al., 1992; Weihe et al., 1993) . Inflammatory tissue produces an increased sensitivity to noxious stimulation (hyperalgesia), and even innocuous stimuli are often perceived as painful. Accompanying these behavioral changes are alterations in the discharge properties ofafferent fibers and neurons in the CNS (Neugebauer and Schaible, 1990; Dubner and Ruda, 1992) , as well as changes in levels of messenger molecules. Thus, it has been shown that peripheral inflammation induces upregulation of the synthesis of opioid peptides Noguchi et al., 1988; Ruda et al., 1988 ; see also Dubner and Ruda, 1992; Weihe et al., 1993) , substance P (SP) (Noguchi et al., 1988) calcitonin gene-related peptide (CGRP) (Hanesch et al., 1993) , glutamate (Sluka et al., 1992) , NADPH-diaphorase (Solodkin et al., 1992) , GABA (Castro-Lopes et al., 1992) and galanin (Tokunaga et al., 1992) . Unilateral inflammation also evokes an increase in the dorsal horn expression of c-j& proto-oncogene (Hunt et al., 1987; Presley et al., 1990; Noguchi et al., 1991; Hylden et al., 1992; Leah et al., 1992) .
With the recent cloning of an increasing number of neuropeptide receptor genes (Meyerhof et al., 1993) , it is now possible to determine the site of synthesis of these receptors at the cellular level. Indeed, inflammation has been shown to induce an elevation in the expression in neurokinin-1 (NKl) receptor (Schlfer et al., 1993) . Furthermore, the synthesis of neuropeptide processing enzymes is also altered (Weihe et al., 1993) . Regarding neuropeptides, perhaps the most striking example is the increase in dynorphin in local dorsal horn neurons (Dubner and Ruda, 1992; Hylden et al., 1992; Parker et al., 1993) .
Neuropeptide Y (NPY), a 36 amino acid peptide originally isolated from porcine brain (Tatemoto, 1982; Tatemoto et al., 1982) , is an important regulatory molecule in both the CNS and PNS (see Mutt et al., 1989; Allen and Koenig, 1992; Dumont et al., 1992) . NPY belongs to a family of peptides also including pancreatic polypeptide (PP) (Lin and Chance, 1974; Kimmel et al., 1975) and peptide YY (PYY) (Tatemoto, 1982; Tatemoto et al., 1982) . At least two major subtypes of NPY receptors, Y 1 and Y2, seem to exist; the Yl receptor is considered to be a postjunctional, and the Y2 one a prejunctional receptor (see Wahlestedt and Reis, 1993) . More recently, the molecular clon-and Expression of NPY and NPY Receptor ing of the cDNA sequence of the Y 1 receptor has been reported (Eva et al., 1990; Herzog et al., 1992; Larhammar et al., 1992) . Immunohistochemical studies have shown that NPY is one of the most abundant and widely distributed peptides within the mammalian CNS (Allen et al., 1983; Chronwall et al., 1985; de Quidt and Emson, 1986) . One area in which NPY-like immunoreactivity (-LI) occurs in high concentrations is the superficial dorsal horn of the spinal cord, where numerous local neurons are NPY positive (Gibson et al., 1984; de Quidt and Emson, 1986 ; see also Hokfelt et al., 1981; Hunt et al., 1981a,b) . Furthermore, a high density of NPY binding sites has been identified in dorsal root ganglia (DRG) and spinal cord Kar and Quirion, 1992) . However, NPY cannot be detected in normal DRG neurons (Gibson et al., 1984; Jazin et al., 1993; Zhang et al., 1994) , whereas NPY (Yl) receptor mRNA has been shown to be present in many neurons in normal DRGs (Jazin et al., 1993; Zhang et al., 1993) . Recently, Wakisaka et al. (1991 Wakisaka et al. ( , 1992 ; see also Zhang et al., 1993) have shown that there is a dramatic upregulation of NPY in primary sensory neurons after peripheral axotomy. Taken together, these studies suggest involvement of NPY in sensory processing in the dorsal horn of the spinal cord. In the present study, we examined the expression of NPY-LI, NPY mRNA, and NPY (Yl) receptor mRNA in the spinal cord and DRG neurons following peripheral tissue inflammation by means of in situ hybridization and immunohistochemistry.
Materials and Methods
Induction ofinflammation. Twenty-five adult male Sprague-Dawley rats weighing 200-250 gm were anesthetized with sodium pentobarbital(40 mg/kg, i.p.), and 200 pl of a 1: 1 emulsion of complete Freund's adjuvant (CFA; Sigma) and saline was injected into the plantar surface of one hindpaw. Control rats received sham injection of saline. Animals were kept in cages (three or four animals in a cage) at an ambient temperature of 20-25°C under a 12/12 hr light/dark cycle and had free access to food and water. The experiments have been approved by Stockholm norra fdrsiiksdjursetiska kommitte and attention was paid to the ethical guidelines for investigation of experimental pain in conscious animals (Zimmermann, 1983) .
In situ hybridization histochemistry. After inoculation, the animals were allowed to survive for 6 hr (n = 3), 24 hr (n = 3), 3 d (n = 4), and 7 d (n = 4). Inflammatory and control rats (n = 4) were decapitated, and the spinal cord (L4-L5) and ipsi-and contralateral LS DRGs were rapidly removed and immediately frozen on dry ice. Before sectioning, experimental and control spinal cords and DRGs were, respectively, fused by saline on the same blocks, so that all groups could be processed under the same conditions. Coronal sections (14 pm thick) were cut in a cryostat (Microm, Heidelberg, Germany), thawed onto "ProbeOn" slides (Fisher Scientific, Pittsburgh, PA), and stored in sealed boxes at -20°C until hybridization.
Oligonucleotide probes were synthesized with an Applied Biosystem DNA synthesizer 318A (Foster City, CA) or purchased from Scandinavian Gene Synthesis AB (Koping, Sweden) and purified through NAP-25 columns (Pharmacia, Uppsalai Sweden) or OPC-columns (Applied Biosvstems). The oliaonucleotide for NPY receptor mRNA was complementary'to the nicleotides 546-585 of the rat NPY Cyl) receptor (Eva et al., 1990) . Sequences for neuropeptide probes were complementary to nucleotides 167 l-l 7 14 of rat NPY mRNA (Larhammar et al., 1987) , nucleotides 87 l-9 18 of rat dynorphin mRNA (Civelli et al., 1985) , and nucleotides 322-360 of rat enkephalin mRNA (Howells et al., 1984) . The oligonucleotide probes were labeled at the 3' end with a-'S-dATP (New Enaland Nuclear. Boston. MA) usina terminal deoxvnucleotide transferase(Amersham)'in a buffer containmg 10 mM Co& 1 mM dithiothreitol (DTT, LKB, Bromma, Sweden), 300 mM Tris base, and 1.4 M potassium cacodylate (pH 7.2). Afterward the labeled probes were purified through Nensorb-20 columns (New England Nuclear), and DTT was added to a final concentration of 10 mM. The specific activities obtained ranged from 2 to 4 x lo6 cpm/ng oligonucleotide.
The present hybridization procedure followed previously published protocols (Schalling, 1990; Young, 1990; Dagerlind et al., 1992) . In brief, sections were air dried and directly hybridized, without pretreatment, for 18 hr at 42°C in humid chambers. The labeled probe was diluted with hybridization buffer containing 50% formamide (G.T. Baker Chemicals BW, Deventer, The Netherlands), 4 x SSC (1 x SSC = 0.15 M NaCl, 0.0015 M sodium citrate), 1 x Denhardt's solution (0.02% each of polyvinylpyrrolidone, bovine serum albumin, and Ficoll), 1% sarkosyl (N-lauryl sarcosine; Sigma), 0.02 M phosphate buffer (pH 7.0), 10% dextran sulfate (Pharmacia, Uppsala, Sweden), 250 &ml yeast tRNA (Sigma), 500 pg/ml sheared and heat-denatured salmon testis DNA (Sigma), and 200 mM DTT, and applied to the slides (lo6 cpm per 100 rllslide). After hybridization the sections were washed (4 x 15 min) in 1 x SSC at 55°C and then cooled to room temperature and dipped twice in distilled water. After dehydration through 60% and 95% ethanol, the slides were dried in air and dipped in NTB2 nuclear track emulsion (Kodak, Rochester, NY) diluted 1: 1 with distilled water, exposed in the dark at 4°C for 4 weeks (peptides) or 6 weeks (NPY recentor). Finallv. the slides were develooed in D-19 (Kodak) for 3 min,
fixed in Kodak 3000A&B for 6 mitt, and rinsed for'30 min in running water. Developed slides were mounted with glycerol, coverslipped, and analyzed in a Nikon Microphot-FX microscope equipped with a darkfield condenser. Subsequently, the slides were lightly stained with toluidine blue, mounted with Entellan (Merck, Darmstadt, Germany), and reexamined under bright-field conditions.
Zmmunohistochemistrv. Three davs after the iniection of CFA. both inflammatory (n = 4) and control rats (n = 3) were deeply anesthetized with sodium pentobarbital(l20 mg/kg, i.p.) and transcardially perfused with 50-100 ml of warm saline, followed by 400 ml of 4% paraformaldehyde with 0.4% pi&c acid in 0.16 M phosphate buffer solution (pH 7.2). The L5 DRGs and the L4 and L5 segments of spinal lumbar enlargement were removed, postfixed in the same fixative for 90 min, and then placed in 10% sucrose solution at 4°C overnight. Tissues were embedded with OCT compound (Tissue Tek, Miles Laboratories, Elkhart, IN), cut coronally in a cryostat at 14 pm thickness, and mounted on to gelatin-coated slides. Sections were processed according to the ABC method (Hsu et al., 198 1) using a polyclonal NPY antibody (1: 4800; CURE/UCLA DDC Antibody-Core, Los Angeles, CA), Fos antibodv (1: 1000: kindlv orovided bv Dr. Iadarola). and ABC Kit (Vector Labs,*Burlingame, Ckj. The sections were incubated for 36 hr at 4°C with the primary antibody, and for 1 hr at 37'C with the secondary antibody and subsequent ABC complex. Finally, the reaction product was visualized with 0.05% DAB/O.OOl% hydrogen peroxide in 0.1 M acetate buffer (pH 6.0) containing 2% ammonium nickel sulfate for 5 min, and then rinsed in acetate buffer, air dried, dehydrated, and coverslipped.
Quantification. For in situ hybridization, counts were done on the sections stained with toluidine blue. The sections were examined under bright field using a 20 x objective lens. Neurons containing five times more grains than mean background grain densities (signal : noise ratio z 5) were counted as positive neurons. Furthermore, some neurons with signal : noise ratio > 10 were classified as strongly labeled. Mean background grain densities were determined by averaging grain counts over defined areas of the neuropil devoid of positively labeled cell bodies. In a 100 pm* area, they were 2.3 +-0.2 (mean + SEM), 2.3 f 0.2, 2.1 ? 0.1, and 1.6 + 0.1 for the hybridization of NPY, NPY (Y 1) receptor, enkephalin, and dynorphin mRNAs, respectively. Percentage of mZU?A-positive neurons in DRGs. The total number of positive neuron profiles was divided by the total number of toluidine blue-stained neuron profiles in the DRG sections, and the percentage of mRNA-positive profiles was calculated. Percentages of five sections from one animal were averaged as the percentage for that animal. Four rats receiving CFA injection surviving for 3 d were used for analysis.
Zmmunoreactivity-positive neurons and fiber network density in the dorsal horn of spinal cord. The total number of positive cells in eight sections (14 pm thickness) were counted for each rat. Four rats, sacrificed 3 d after CFA injection, were used for analysis. As shown in Figure 6a, the relative immunostaining density level was measured in a 127 x 76 pm* area in the medial lamina II of the spinal cord. Twenty sections of spinal cord from four rats were analyzed. The measurements were performed on a Macintosh 11x computer (Apple Computer Inc., Cupertino, CA), equipped with a Quick Capture frame grabber board (Data Translation, Marlboro, MA) and a Cage-MT1 72 CCD series camera (DAGE-MTI, Michigan City, IN) connected with a Nikon microscope. Image processing was performed with IMAOE software (courtesy by Dr. W. Rasband, NIMH). Each image was digitized with 256 gray levels for each picture element. The density level on the inflammatory side was expressed as percentage of contralateral side, which was set to 100%.
Size ofNPY receptor (YI) mRNA-positive neurons in DRGs. By using the above-mentioned program, the size of neuron profiles in DRG sections from control and inflammation animals was measured. For each group 150 neurons of four DRG sections from four rats were measured.
Statistics. All data were assessed using the two-tail paired t test. The criterion for statistical significance was P < 0.05.
Control experiments. Hybridization control was carried out with an excess of cold probe (loo-fold) together with the labeled probe. The specificity of immunostaining was tested by preabsorbing the anti-NPY 
Results
NPY mRNA-positive neurons in the spinal cord In the L4-L5 segments of the spinal cord of control rats, NPY mRNA-positive neurons were mainly distributed in lamina II (Fig. la,&. A few labeled neurons could also be seen in laminae I, III, V, and X. On the side contralateral to the inflammation, no significant change in NPY mRNA expression was found as compared to control animals ( Fig. 1 c,e,g ). In the ipsilateral spinal cord inflammation induced a marked increase in the number of positive neurons. The increase was observed as early as 6 hr after injection of adjuvant, and reached a peak at 3 d, and the levels were back to normal at 7 d (Figs. 1,2 ). The neurons with increased NPY mRNA levels were mainly concentrated in the medial part of lamina II in the dorsal horn (Figs. 1, 3 ). There was a 88% elevation (P < 0.00 1) in the number ofNPY mRNApositive neurons in the ipsilateral side 3 d postinjection as compared to the contralateral side (Table 1) . Furthermore the intensity of labeled cells was dramatically enhanced on the ipsilateral side (Fig. 4) . When comparing only the strongly labeled neurons, the increase was even more pronounced (Fig. 3 ). For comparison, the elevation in the expression of dynorphin and enkephalin mRNA was monitored on adjacent sections from the ipsilateral spinal dorsal horn (Fig. 5 ). Three days after CFA injection, there was a 96% (P < 0.0 1) and a 33% (P < 0.01) Results are presented as the mean + SEM for 16 sections (14 pm thickness) taken from four rats (four sections/rat). Significance was examined by paired t test. Adjacent sections were used for in situ hybridization of these three pcptide mRNAs. **p < 0.01. ***p < 0.001. elevation in the number of mRNA-positive neurons for dynorphin and enkephalin, respectively (Table 1 ).
NPY immunoreactivity in the spinal cord
In control rats, only few NPY-immunoreactive (-IR) neurons were seen in a 14-pm-thick section. These neurons were mainly distributed in lamina II of the spinal dorsal horn. However, a dense network of NPY-IR fibers was observed particularly in laminae I-II, but also in the deeper laminae III-V and the central canal region. Peripheral inflammation caused an moderate increase in the number of NPY-IR neurons in the ipsilateral dorsal horn ( Fig. 6a-d) . These neurons were small and present in the medial part of lamina II. As shown in Table 2 , there was a 56.8% increase (P < 0.01) in the ipsilateral dorsal horn as compared to the contralateral side. In addition, there was also an increase (62.9%, P < 0.05) in NPY immunoreactivity in the medial lamina II of the ipsilateral side (Table 2, Fig. 6a-d) . In adjacent spinal sections CFA induced a marked increase in the number of c-Fos-positive neurons. These neurons were mainly located in the medial part of laminae I-II, as well as in lamina V in the ipsilateral dorsal horn. A few c-Fos-positive neurons were observed in laminae I-V of the contralateral dorsal horn (Fig. Se&. 
NPY mRNA and NPY-immunoreactive neurons in DRG
No NPY mRNA-positive or NPY-IR neurons were detected in the ipsilateral or contralateral L5 DRGs after CFA injection ( Fig. 7a-d) . Results are presented as number of positive neurons in eight sections (mean f SEM, n = 4) and staining density from 20 sections (five sections/rat, 14 pm thickness; n = 4) (mean + SEM). Significance between the ipsilateral and contralateral sides was examined by paired t test. * p < 0.05. **p < 0.01. Results are presented as the mean * SEM of 16 spinal cord sections taken from four rats (four sections/rat), and of 20 DRG sections taken from four rats (five sections/rat). Significant difference between the ipsilateral and contralateral sides was evaluated by paired t test. *p < 0.05.
NPY (Yl) receptor mRNA-positive neurons in spinal cord
In control rats, Y 1 receptor mRNA-positive neurons were mainly distributed in lamina II, but positive neurons could also be observed in deeper laminae (Fig. 8a,b) . A marked elevation in the expression ofY 1 receptor mRNA was found in the ipsilateral spinal dorsal horn 1 and 3 d following inflammation (Fig. 8c-f ). The increase in labeled neurons was mainly seen in the medial part of laminae II and III (Figs. 3b, 8df ). There was a 59% increase (P < 0.05) in the number of Y 1 mRNA-positive neurons at 3 d in the ipsilateral spinal dorsal horn, as compared to the contralateral side (Table 3) .
NPY (YI) receptor mRNA-positive neurons in DRG
Numerous Y 1 receptor mRNA-positive neurons were found in the DRGs (L5) of control rats. The majority were small neurons. There was a significant elevation of Y 1 receptor mRNA expression in the ipsilateral DRG 3 d after inflammation (Fig.  7eJ ). In the contralateral DRG, 17.3 + 0.9% (mean f SEM) of the toluidine blue-positive cell profiles were Y 1 receptor mRNA positive. The percentage increased to 23.1 f 0.9% (P < 0.05) in the ipsilateral DRG (Table 3) . There was no significant change in the size of neuron profiles, and most of them were still small ones with a size range from 250 to 450 pm2 (Figs. 7e,f; 9A,B).
Control experiments
An excess of cold probe completely abolished the mRNA signal for peptides and the receptor. There was no positive immunohistochemical staining after peptide absorption or omission of the primary antisera.
Discussion
The present study shows that injection of CFA into the paw causes a rapid and marked increase in NPY peptide and NPY mRNA levels in the dorsal horn of spinal cord. A marked elevation of dynorphin and enkephalin mRNA level was also found in adjacent sections of spinal cord, confirming previous observations (Ruda et al., 1988; Noguchi et al., 1989; Dubner and Ruda, 1992) and supporting the validity of our inflammatory model. It is worthwhile to point out that the enhancement of NPY mRNA appears as pronounced as that of dynorphin. The changes in peptide and in mRNA levels after inflammation were confined to the ipsilateral side, and therefore the noninjected side of spinal cord and DRG could be used as a control together with control rats, which is also consistent with many previous reports (Ruda et al., 1988; Noguchi et al., 1989 ; Dubner and Ruda, 1992; Tokunaga et al., 1992; Hanesch et al., 1993) . Finally, the increase in the expression of c-Fos protein ulation and confirms several earlier studies (Hunt et al., 1987;  in the ipsilateral laminae I, II, and V, where the majority of Presley et al., 1990; Noguchi et al., 1991; Hylden et al., 1992; Leah et al., 1992) . noxious primary afferents terminate and where dorsal horn nociceptive neurons predominate (Sugiura et al., 1986; Besson and Chaouch, 1987) further supports a long-lasting noxious stimThe fact that both histochemical techniques, in situ hybridization and immunohistochemistry, revealed an increase in the number of cells on the inflammatory side strongly indicates that these cells indeed increase their synthesis of NPY peptide. The number of cells visualized with the two techniques was, however, not the same, which may reflect not only the sensitivity of the methodologies but also differences in the rate of transcription versus production of the mature peptide, or in the balance between synthesis and release of peptide. Furthermore, both increases occurred ipsilaterally in the spinal cord segments corresponding to the hindlimb dermatomes, and took place preferentially in the medial zone of the dorsal horn, which contains the somatopic projection from the various parts of the foot (Molander and Grant, 1985) . However, no NPY mRNA or NPY-immunoreactive neurons were found in the DRGs in either normal or inflammatory animals, in accordance with a previous study (Wakisaka et al., 1992) and in sharp contrast to the dramatic elevation of NPY mRNA and NPY immunoreactivity in DRG neurons after axotomy (Wakisaka et al., 199 1, 1992; Zhang et al., 1993) .
Sources of NPY in the dorsal horn
In the spinal cord, NPY-LI is present in high concentrations in the dorsal horn, especially in the substantia gelatinosa (Gibson et al., 1984; de Quidt and Emson, 1986) . The most likely source for NPY in the dorsal horn is the numerous NPY-immuno-. reacttve cell bodies in laminae I-III, especially in lamina II, giving rise to a dense NPY-immunoreactive fiber plexus in laminae I and II (Gibson et al., 1984; de Quidt and Emson, 1986 ; see also Hokfelt et al., 1981; Hunt et al., 1981a,b) . A further possibility is that descending, bulbospinal systems may contain and release NPY. For example, it is known that a proportion of the noradrenergic locus coereulus neurons contain NPY-LI (Eve&t et al., 1984) , but only some of these neurons seem to project to the spinal cord (Holets et al., 1988) . The local neurons were demonstrated early using an antiserum raised to avian pancreatic polypeptide (APP), and transection of the cord and dorsal rhizotomy failed to alter APP-LI, suggesting presence in local spinal neurons (Hokfelt et al., 198 1; Hunt et al., 198 1 a, b) . This view was further supported by the fact that NPY could not be demonstrated in primary sensory neurons (Gibson et al., 1984) . The present demonstration of a strong upregulation of NPY synthesis and peptide levels in local dorsal horn neurons further supports an involvement in pain related to inflammatory state. Whether or not NPY synthesis and peptide levels are changed in supraspinal structures under inflammatory conditions remains to be determined. Therefore, it will be important to study whether or not descending systems or primary afferent fibers make synaptic contact with the NPY interneurons following inflammation.
Comparison with axotomy
The present results further underline the distinct difference in the response to, on the one hand, the inflammatory process (see Dubner and Ruda, 1992; Weihe et al., 1993) and, on the other hand, axotomy (see Hijkfelt et al., 1994) , both processes that result in pain (Wall and Devor, 1981; Devor, 1984) . Thus, a very dramatic increase in NPY synthesis and peptide level was found in DRGs after axotomy (Wakisaka et al., 1991 (Wakisaka et al., , 1992 Zhang et al., 1993) . In contrast, no change in DRGs was detected following inflammation, as also shown by Wakisaka et al. (1992) . Furthermore, sciatic nerve transection induced a decrease in levels of Y 1 receptor mRNA in small DRG neurons , whereas inflammation evoked an increase of Y 1 receptor mRNA-positive neurons in DRGs. Moreover, axotomy induced a shift in Y 1 receptor mRNA expression from small to large neurons ), but such a shift was not observed after inflammation. In addition, there was no marked change in the expression of NPY and Y 1 receptor mRNA in spinal cord after axotomy , whereas in the present study inflammation induced a moderate upregulation of NPY peptide and Y 1 receptor mRNA in the spinal cord. In fact, Wakisaka et al. (1992) did not observe any effect on dorsal horn NPY-LI after CFA injection. Finally, inflammation-evoked upregulation of NPY mRNA in the dorsal horn disappeared in 1 week, whereas axotomy-evoked alterations in DRGs lasted at least for several weeks (Wakisaka et al., 1991; Zhang et al., 1993) . It is important to note the transient nature of the CFAinduced inflammation in contrast to permanent effect of axotomy. Nevertheless, inflammation-induced changes seem mainly to be confined to the spinal cord level, whereas axotomy affects primary sensory neurons, indicating distinctly different mechanisms involved in the regulation of peptides. These changes may not only affect processing of nociception but may also be of importance for regenerative events, especially in the case of axotomy.
Possible function of NPY A number of direct effects of NPY on DRG cells in vivo and in cultures have been demonstrated. NPY was found to inhibit Ca2+ currents in sensory neurons mediated via G, protein, to stimulate the synthesis of inositol triphosphate and diacylglycerol, and to increase cytoplasmic free Ca2+ concentrations from an intracellular store Walker et al., 1988; Pemey and Miller, 1989; Bleakman et al., 1991) . Walker et al. (1988) have demonstrated high-affinity 12SI-NPY binding sites on cultured DRG cells. Moreover, NPY could effectively inhibit the depolarization-evoked the release of SP from DRGs , as well as stimulation-induced release of SP from spinal cord (Duggan et al., 1991) . More recently, further information on the mechanism of action of NPY has become available. NPY has been found to exert a presynaptic inhibition at sympathetic nerve terminals associated with a reduction in Ca2+ influx due to the selective inhibition of neuronal N-type Caz+ channels (Toth et al., 1993) . Furthermore, intrathecal injection of NPY causes a strong inhibition of spinal nociceptive reflexes in anaesthetised rats (Hua et al., 199 1 Autoradiographic binding studies with 1z51-PYY as ligand have shown a dense labeling in the superficial layers in the dorsal horn, and this binding is markedly reduced after capsaicin treatment, dorsal rhizotomy, and peripheral nerve section, suggesting that at least some of these NPY binding sites are located in the terminals of primary sensory afferents (Kar and Quirion, 1992) . Our previous attempts to correlate the distribution of NPY Y 1 receptor mRNA with various neuropeptides have shown a strong coexistence with SP mRNA in small sensory neurons in normal rats , providing a further morphological basis for an interaction.
of Neuroscience, November 1994, 74(11) 6433 Rowan et al. (1993) have recently shown that all NPY-immunoreactive cell bodies in laminae I-III of rat dorsal horn are GABA immunoreactive, and an increase in GABAergic and GABA levels has also been detected in the ipsilateral spinal cord following unilateral inflammation (Castro-Lopes et al., 1992) . It is thus possible the dorsal horn intemeurons may upregulate two coexisting messenger molecules, GABA and NPY, after peripheral inflammation. GABA nerve endings form axoaxonic contacts with primary afferent boutons (Barber et al., 1978; Todd and Lockhead, 1990) , and GABA, and GABA, receptors are present on the central nerve endings of primary afferents (Singer and Placheta, 1980; Price et al., 1984) . It may therefore be that NPY and GABA, in a concerted action via presynaptic effects, inhibit transmission in the dorsal horn. After inflammation this effect should be strengthened by the concomitant upregulation of Y 1 receptors in many small primary sensory neurons, resulting in increased sensitivity to NPY released in the dorsal horn. Since inflammation also induced upregulation of sustance P and CGRP in small sensory neurons (Noguchi et al., 1988; Hanesch et al., 1993) , and since NPY (Y 1) receptor mRNA colocalized with SP mRNA and CGRP mRNA , the NPY released may counteract the noxious effect that the upregulated SP may exert in the dorsal horn. Finally, there was also a Y 1 receptor mRNA upregulation in laminae II-III. How these neurons are involved in local circuitry is unknown and the functional significance remains to be evaluated.
Concluding remarks
Unilateral peripheral inflammation produced by injection of CFA into the hindpaw induces a distinct increase in the expression of NPY mRNA in the ipsilateral spinal dorsal horn. The upregulation that is also shown by immunohistochemical data is as dramatic as that for dynorphin mRNA. A significant increase in the expression of NPY (Yl) receptor was also found in the ipsilateral dorsal root ganglion (L5) and in the spinal dorsal horn after inflammation. These data strongly suggest that NPY and its Yl receptor participate in the modulation of inflammation and nociception.
